MYCN mediates cysteine addiction and sensitizes to ferroptosis

Hamed Alborzinia(German Cancer Research Center), Frank Westermann(German Cancer Research Center), Daniel Dreidax, Carlo Stresemann(Bayer (Germany)), Moritz Gartlgruber(German Cancer Research Center), Andrés F. Flórez(Harvard University), Thomas Höfer(Heidelberg University), Elisa M. Hess(German Cancer Research Center), Matthias Ziehm(Max Delbrück Center), Marjan Shaikhkarami(Heidelberg University), Barbara Nicke(Target (Germany)), Jan H. Reiling(The University of Texas MD Anderson Cancer Center), Gernot Poschet(Heidelberg University), Matthias Selbach(Max Delbrück Center), Carl Herrmann(German Cancer Research Center), Ido Amit(Weizmann Institute of Science), Emma Bell(Ontario Institute for Cancer Research), Jochen Kreth(German Cancer Research Center), Matthias Fischer(University of Cologne), Franziska Paul(Weizmann Institute of Science), Stefan Wölfl(Institute of Molecular Biotechnology), Sina Gogolin(German Cancer Research Center), Lena Brückner(German Cancer Research Center), Michael Büttner(Heidelberg University), Kai‐Oliver Henrich(Heidelberg University), Chunxuan Shao(German Cancer Research Center), Sebastian Steinhauser(Novartis (Switzerland)), Sabine Hartlieb(German Cancer Research Center), Michal Nadler-Holly(Max Delbrück Center)
bioRxiv (Cold Spring Harbor Laboratory)
August 10, 2021
Cited by 2


Related Papers